The epidemiology of Parkinson's disease
- PMID: 9426868
The epidemiology of Parkinson's disease
Abstract
Epidemiological research has confirmed that Parkinson's disease (PD) is found throughout the world and increases exponentially with age. Few good-quality data on the temporal incidence of PD are available, although both mortality and incidence data suggest that the disease may be less common today in younger age groups. Differences in prevalence between identical ethnic groups in different countries support the role of an environmental factor. Any postulated factor must be found commonly in developed countries, among which there appears to be little difference in incidence or prevalence rates. A wide variety of aetiological agents have been considered from infectious, toxic and other exposures. The most robust finding is that non-smokers have a greater risk of disease, although the reason for this is unclear and may relate to differences in pre-morbid personality. Pesticides and head injuries also show consistently elevated risk but are prone to biased measurement. Dietary anti-oxidants require further evaluation. Future research needs to improve on current limited methods of exposure measurement and to attempt more novel designs to overcome bias. More attention should be made on examining what factors determine prognosis and using epidemiological and qualitative methods to determine the needs of patients with PD.
Similar articles
-
Environmental, medical, and family history risk factors for Parkinson's disease: a New England-based case control study.Am J Med Genet. 1999 Dec 15;88(6):742-9. Am J Med Genet. 1999. PMID: 10581500
-
Epidemiologic studies of environmental exposures in Parkinson's disease.J Neurol Sci. 2007 Nov 15;262(1-2):37-44. doi: 10.1016/j.jns.2007.06.024. Epub 2007 Jul 27. J Neurol Sci. 2007. PMID: 17673256 Review.
-
Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study.J Neurol. 2003 Oct;250 Suppl 3:III30-9. doi: 10.1007/s00415-003-1306-7. J Neurol. 2003. PMID: 14579122
-
Environmental factors and Parkinson's disease: a case-control study in the Tuscany region of Italy.Parkinsonism Relat Disord. 2004 Dec;10(8):481-5. doi: 10.1016/j.parkreldis.2004.01.008. Parkinsonism Relat Disord. 2004. PMID: 15542008
-
Epidemiology and etiology of Parkinson's disease: a review of the evidence.Eur J Epidemiol. 2011 Jun;26 Suppl 1:S1-58. doi: 10.1007/s10654-011-9581-6. Epub 2011 May 28. Eur J Epidemiol. 2011. PMID: 21626386 Review.
Cited by
-
Caspase-1 causes truncation and aggregation of the Parkinson's disease-associated protein α-synuclein.Proc Natl Acad Sci U S A. 2016 Aug 23;113(34):9587-92. doi: 10.1073/pnas.1610099113. Epub 2016 Aug 1. Proc Natl Acad Sci U S A. 2016. PMID: 27482083 Free PMC article.
-
A critical review of radiotracers in the positron emission tomography imaging of traumatic brain injury: FDG, tau, and amyloid imaging in mild traumatic brain injury and chronic traumatic encephalopathy.Eur J Nucl Med Mol Imaging. 2021 Feb;48(2):623-641. doi: 10.1007/s00259-020-04926-4. Epub 2020 Jul 21. Eur J Nucl Med Mol Imaging. 2021. PMID: 32696090 Review.
-
Treatment benefit and daily drug costs associated with treating Parkinson's disease in a Parkinson's disease clinic.CNS Drugs. 2004;18(2):105-11. doi: 10.2165/00023210-200418020-00004. CNS Drugs. 2004. PMID: 14728057
-
[Frequency and clinical profile of Parkinson's disease and other Parkinsonian syndromes seen in the Department of Neurology at the Befelatanana Hospital Antananarivo].Pan Afr Med J. 2019 Jul 18;33:229. doi: 10.11604/pamj.2019.33.229.19361. eCollection 2019. Pan Afr Med J. 2019. PMID: 31692664 Free PMC article. French.
-
Sequential and concerted gene expression changes in a chronic in vitro model of parkinsonism.Neuroscience. 2008 Mar 3;152(1):198-207. doi: 10.1016/j.neuroscience.2007.11.029. Neuroscience. 2008. PMID: 18191903 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Medical